Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
716
NCT00190047
Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2005
Completion: Oct 31, 2006
NCT00640965
DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study
Start: Jul 31, 2008
Completion: Aug 31, 2009
NCT00893867
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
Phase: Phase 3
Start: Dec 31, 2009
Completion: Apr 30, 2012
NCT01957774
THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA
Start: Oct 31, 2013
Completion: Not specified
NCT02025049
DP-b99 in the Treatment of Acute High-risk Pancreatitis
Start: Dec 31, 2013
Completion: May 31, 2015
NCT02572336
A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA
Start: Oct 31, 2015
Completion: Apr 30, 2016